AbCellera Biologics (ABCL)
(Delayed Data from NSDQ)
$3.64 USD
-0.14 (-3.70%)
Updated May 17, 2024 04:00 PM ET
After-Market: $3.64 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
AbCellera Biologics Inc. [ABCL]
Reports for Purchase
Showing records 1 - 19 ( 19 total )
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Digital Biology Tech- Enabled Drug Discovery Initiation
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
2Q-2023 Results : Slower pace of pertne, but long term Trajectory Remains on Track
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
1Q-2023 Revenues and Partnerships Light: Progress on Partnered Programs shows Platform potential
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
4Q-2022 Results-Light on Revenue, But Pipeline Momentum Builds.
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
FY-2021 Results Shifting focus to Program starts but Strategy Unchanged.
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
|